Loading clinical trials...
Loading clinical trials...
Fatty liver is known to be one of the most frequent liver pathologies in IBD patients (35-40%). Despite this fact, there are only few publications that evaluated the prevalence of fatty liver in IBD p...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tel-Aviv Sourasky Medical Center
NCT05330923 · Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and more
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT03481829 · Diabetes Mellitus, Obesity, and more
NCT06483373 · Inflammatory Bowel Disease
NCT06810518 · Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Inflammatory Bowel Syndrome
Tel Aviv Sourasky Medical center
Tel Aviv
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions